Hiromi Kan
- Epidemiology top 10%
- Hepatology top 5%
- Endocrinology, Diabetes and Metabolism
- Surgery
- Molecular Biology
- Co-authors
- Kazuaki ChayamaHiroshi AikataMichio ImamuraMasataka TsugeHidenori OchiHideyuki HyogoAkira HiramatsuYoshiiku Kawakami
- Topics
- Liver Disease Diagnosis and Treatment (16 papers)Hepatitis C virus research (15 papers)Hepatitis B Virus Studies (9 papers)
- Partner nations
- JapanUnited StatesItaly
In The Last Decade
Hiromi Kan
31 papers receiving 451 citations
Peers
Comparison fields: 5 of 53
- Epidemiology 317
- Hepatology 273
- Endocrinology, Diabetes and Metabolism 88
- Surgery 77
- Molecular Biology 52
Countries citing papers authored by Hiromi Kan
This map shows the geographic impact of Hiromi Kan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiromi Kan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiromi Kan more than expected).
Fields of papers citing papers by Hiromi Kan
This network shows the impact of papers produced by Hiromi Kan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiromi Kan. The network helps show where Hiromi Kan may publish in the future.
Co-authorship network of co-authors of Hiromi Kan
This figure shows the co-authorship network connecting the top 25 collaborators of Hiromi Kan. A scholar is included among the top collaborators of Hiromi Kan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiromi Kan. Hiromi Kan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 15 | |
| 3 | 18 | |
| 4 | 8 | |
| 5 | 8 | |
| 6 | 21 | |
| 7 | 11 | |
| 8 | 19 | |
| 9 | 25 | |
| 10 | 2 | |
| 11 | 7 | |
| 12 | 15 | |
| 13 | 7 | |
| 14 | 22 | |
| 15 | A case of syndrome of inappropriate secretion of antidiuretic hormone following transarterial embolization with cisplatin. | 2 |
| 16 | Efficacy and safety of sitagliptin for the treatment of nonalcoholic fatty liver disease with type 2 diabetes mellitus. | 48 |
| 17 | 7 | |
| 18 | 17 | |
| 19 | 23 | |
| 20 | 14 |
About Hiromi Kan
Hiromi Kan is a scholar working on Hepatology, Microbiology and Epidemiology, having authored 32 papers that have together received 460 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (16 papers), Hepatitis C virus research (15 papers) and Hepatitis B Virus Studies (9 papers). The work is most often cited by research in Hepatology (273 citations), Epidemiology (317 citations) and Endocrinology, Diabetes and Metabolism (88 citations). Hiromi Kan has collaborated with scholars based in Japan, United States and Italy. Frequent co-authors include Kazuaki Chayama, Hiroshi Aikata, Michio Imamura, Masataka Tsuge, Hidenori Ochi, Hideyuki Hyogo, Akira Hiramatsu, Yoshiiku Kawakami, Nobuhiko Hiraga and Takayuki Fukuhara. Their work appears in journals such as PLoS ONE, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.